These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 5301733)

  • 21. Antimicrobial suceptibility of V. cholerae in north west, Ethiopia.
    Abera B; Bezabih B; Dessie A
    Ethiop Med J; 2010 Jan; 48(1):23-8. PubMed ID: 20607994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparative in vitro study of antibiotic resistance increase in classical cholera and E1 Tor vibrios].
    Ganin VS; Khundanov LE; Navashin SM
    Antibiotiki; 1971 Sep; 16(9):831-4. PubMed ID: 4333292
    [No Abstract]   [Full Text] [Related]  

  • 23. Outpatient, sequential, parenteral-oral antibiotic therapy for lower risk febrile neutropenia in children with malignant disease: a single-center, randomized, controlled trial in Argentina.
    Paganini H; Gómez S; Ruvinsky S; Zubizarreta P; Latella A; Fraquelli L; Iturres AS; Casimir L; Debbag R
    Cancer; 2003 Apr; 97(7):1775-80. PubMed ID: 12655535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intraperitoneal fluid therapy in cholera and non-cholera diarrhoea: with special emphasis on the treatment of infants and children.
    Mahalanabis D; Sack RB; Kaplan J; Jacobs B; Mondal A
    Bull World Health Organ; 1970; 42(6):837-46. PubMed ID: 5312247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single dose ciprofloxacin in cholera.
    Usubütün S; Ağalar C; Diri C; Türkyilmaz R
    Eur J Emerg Med; 1997 Sep; 4(3):145-9. PubMed ID: 9426995
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emergence of tetracycline-resistant Vibrio cholerae O1 serotype Inaba, in Kolkata, India.
    Roychowdhury A; Pan A; Dutta D; Mukhopadhyay AK; Ramamurthy T; Nandy RK; Bhattacharya SK; Bhattacharya MK
    Jpn J Infect Dis; 2008 Mar; 61(2):128-9. PubMed ID: 18362401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical studies of the use of bacteriophage in the treatment of cholera.
    Marcuk LM; Nikiforov VN; Scerbak JF; Levitov TA; Kotljarova RI; Naumsina MS; Davydov SU; Monsur KA; Rahman MA; Latif MA; Northrup RS; Cash RA; Hug I; Dey CR; Phillips RA
    Bull World Health Organ; 1971; 45(1):77-83. PubMed ID: 4946956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tetracycline prophylaxis in families of cholera patients.
    McCormack WM; Chowdhury AM; Jahangir N; Ahmed AB; Mosley WH
    Bull World Health Organ; 1968; 38(5):787-92. PubMed ID: 4880663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single dose tetracycline in cholera.
    Islam MR
    Gut; 1987 Aug; 28(8):1029-32. PubMed ID: 3311904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of furoxone: a perspective.
    Phillips KF; Hailey FJ
    J Int Med Res; 1986; 14(1):19-29. PubMed ID: 3514312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized clinical trial to compare the efficacy of erythromycin, ampicillin and tetracycline for the treatment of cholera in children.
    Roy SK; Islam A; Ali R; Islam KE; Khan RA; Ara SH; Saifuddin NM; Fuchs GJ
    Trans R Soc Trop Med Hyg; 1998; 92(4):460-2. PubMed ID: 9850410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cholera epidemic in Baghdad during 1999: clinical and bacteriological profile of hospitalized cases.
    Al-Abbassi AM; Ahmed S; Al-Hadithi T
    East Mediterr Health J; 2005; 11(1-2):6-13. PubMed ID: 16532666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Controlled comparison of tetracycline and furazolidone in cholera.
    Pierce NF; Banwell JG; Mitra RC; Caranasos GJ; Keimowitz RI; Thomas J; Mondal A
    Br Med J; 1968 Aug; 3(5613):277-80. PubMed ID: 4873660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibiotic treatment for urinary tract infections in pediatric patients.
    Hellerstein S
    Minerva Pediatr; 2003 Oct; 55(5):395-406. PubMed ID: 14608263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tetracycline resistant cholera in Kelantan.
    Ranjit K; Nurahan M
    Med J Malaysia; 2000 Mar; 55(1):143-5. PubMed ID: 11072502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of undernutrition on infection with Vibrio cholerae O1 and on response to oral cholera vaccine.
    Glass RI; Svennerholm AM; Stoll BJ; Khan MR; Huda S; Huq MI; Holmgren J
    Pediatr Infect Dis J; 1989 Feb; 8(2):105-9. PubMed ID: 2704600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endemic cholera in Delhi, 1995: analysis of data from a sentinel centre.
    Singh J; Sachdeva V; Bhatia R; Bora D; Jain DC; Sokhey J
    J Diarrhoeal Dis Res; 1998 Jun; 16(2):66-73. PubMed ID: 9805411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of standard glucose-based and reduced-osmolarity maltodextrin-based oral rehydration solutions: effect of sugar malabsorption.
    el-Mougi M; Hendawi A; Koura H; Hegazi E; Fontaine O; Pierce NF
    Bull World Health Organ; 1996; 74(5):471-7. PubMed ID: 9002327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Role of antibiotics in the ecology of cholera vibrios].
    Podosinnikova LS
    Antibiotiki; 1977 Apr; 22(4):371-7. PubMed ID: 329747
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical, microbiological and antibiotic susceptibility patterns of diarrhoea in Korem, Ethiopia.
    Desenclos JC; Zergabachew A; Desmoulins B; Chouteau L; Desve G; Admassu M
    J Trop Med Hyg; 1988 Dec; 91(6):296-301. PubMed ID: 2905012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.